换一批
换一批Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial
作者：
Kim, Dong-Wan [1]
;
Mehra, Ranee [2]
;
Tan, Daniel S. W. [3]
;
Felip, Enriqueta [4]
;
Chow, Laura Q. M. [5]
;
Camidge, D. Ross [6]
;
Vansteenkiste, Johan [7]
;
Sharma, Sunil [8]
;
De Pas, Tommaso [9]
;
Riely, Gregory J. [10]
;
Solomon, Benjamin J. [11]
;
Wolf, Juergen [12]
;
Thomas, Michael [13]
;
Schuler, Martin [14]
;
Liu, Geoffrey [15]
;
Santoro, Armando [16]
;
Sutradhar, Santosh [17]
;
Li, Siyu [18]
;
Szczudlo, Tomasz [19]
;
Yovine, Alejandro ;
Shaw, Alice T.
作者单位：
Massachusetts Gen Hosp, Boston, MA 02114 USA
[1]
Novartis Pharmaceut, E Hanover, NJ USA
[2]
Huntsman Canc Inst, Salt Lake City, UT USA
[3]
Univ Hosp KU Leuven, Leuven, Belgium
[4]
Novartis Pharma AG, Basel, Switzerland
[5]
Ist Europeo Oncol, Milan, Italy
[6]
Natl Canc Ctr, Singapore, Singapore
[7]
Univ Hosp Cologne, Ctr Integrated Oncol, Cologne, Germany
[8]
Vall dHebron Univ, Barcelona, Spain
[9]
Univ Colorado, Denver, CO 80202 USA
[10]
Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[11]
Seoul Natl Univ Hosp, Seoul 110744, South Korea
[12]
Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[13]
Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[14]
Princess Margaret Canc Ctr, Toronto, ON, Canada
[15]
Univ Washington, Seattle, WA 98195 USA
[16]
Univ Klinikum Heidelberg, Translat Lung Res Ctr Heidelberg TLRC H, Thoraxklin, Internist Onkol
[17]
IRCCS Inst Clin Humanitas, Milan, Italy
[18]
Univ Duisburg Essen, Univ Hosp Essen, German Canc Consortium DKTK, Partner Site Univ Hosp Essen
[19]
期刊：
《The lancet oncology》
2016年17卷4期452-463页
发布时间：
2017-04-06
- 翻译满意度评价：
- 提交
- 浏览：4
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
